2004/128/EC: Commission Decision of 23 January 2004 on financial assistance from the Community for the storage of antigens for production of foot-and-mouth disease vaccines in France, Italy and the United Kingdom in 2004 (Text with EEA relevance) (notified under document number C(2004) 102)

• Articles: 6

Article 1

1. The Community shall grant financial assistance to Agence Française de Securité Sanitaire des Aliments for the stocking of antigens for the production of foot-and-mouth disease vaccines at the premises of Agence Française de Securité Sanitaire des Aliments, Lyon.

2. For the period from 1 January to 31 December 2004 the maximum amount of financial assistance shall be EUR 30000.

Article 2

1. The Community shall grant financial assistance to Istituto Zooprofilattico Sperimentale di Brescia for the stocking of antigens for the production of foot-and-mouth disease vaccines at the premises of Istituto Zooprofilattico Sperimentale di Brescia.

2. For the period from 1 January to 31 December 2004 the maximum amount of financial assistance shall be EUR 30000.

Article 3

1. The Community shall grant financial assistance to Merial S.A.S. with its headquarters in Lyon, France, for the stocking of antigens for the production of foot-and-mouth disease vaccines at the premises of Merial S.A.S., Lyon, France, and at the premises of Merial S.A.S., Pirbright, United Kingdom.

2. For the period from 1 January to 31 December 2004 the maximum amount of financial assistance shall be EUR 81047.

Article 4

1. The Community's financial assistance referred to in Article 1(2), Article 2(2) and Article 3(2) shall only be granted if the conditions provided for in Article 4 of Decision 91/666/EEC are complied with and the information and documents provided for in paragraph 2 are submitted to the Commission by 28 February 2005 at the latest.

2. The information and documents referred to in paragraph 1 shall include the following:

(a) technical information on:

(i) the amount and type of antigen stored (storage records),

(ii) storage equipment used (type, number and capacity of tanks),

(iii) security systems in place (temperature control, anti-theft measures),

(iv) insurance arrangements (fire, accidents);

(b) financial information (completion of a form based on the model set out in the Annex).

Article 5

This Decision is addressed to the Agence Française de Securité Sanitaire des Aliments, 31, avenue Tony Garnier, BP 7033, F-69342 Lyon Cedex 07, France, Istituto Zooprofilattico Sperimentale di Brescia, Via Bianchi 9, I-25124 Brescia, Italy, and Merial S.A.S., 29, avenue Tony Garnier, BP 7123, F-69002 Lyon Cedex 07, France.

Done at Brussels, 23 January 2004.

For the Commission

David Byrne

Member of the Commission

(1) OJ L 224, 18.8.1990, p. 19. Decision as last amended by Regulation (EC) No 806/2003 (OJ L 122, 16.5.2003, p. 1).

(2) OJ L 368, 31.12.1991, p. 21.

(3) OJ L 33, 8.2.2000, p. 19.

Schedules & Appendices

ANNEX

Financial information related to the storage of antigens for production of foot-and-mouth disease vaccines

>PIC FILE= "L_2004037EN.002602.TIF">